Etoricoxib vs placebo
Exacerbation of IBD · IBD patients
Etoricoxib showed no clear difference in exacerbation of IBD compared with placebo (low certainty).
1 finding from 1 review
- Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of… 2014 · Cochrane Headline outcomes onlyRR 0.88 [0.45, 1.69]1 study · 159 participantsLow